Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increasing funding for epilepsy research.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to the answer I gave to the Hon. Member for Knowsley on 6 January to Question 101055.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to request that NICE conduct an exceptional (expedited) partial review of the NICE Depression guideline (NG222) to consider the inclusion of intravenous racemic ketamine as an option for patients for whom electroconvulsive therapy is being considered.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department has no plans to ask the National Institute for Health and Care Excellence (NICE) to conduct a review of the NICE guideline on the treatment and management of depression, reference code NG222.
NICE is an independent body and is responsible for taking decisions on whether its guidelines should be updated in light of new evidence and changes in clinical practice. NICE operates an active surveillance programme and when new evidence emerges, it proactively considers whether existing guidance should be reviewed and, if appropriate, updated. Decisions as to whether NICE will create new, or update existing, guidance are overseen by an integrated, cross-organisational prioritisation board. NICE has no current plans to review intravenous racemic ketamine in the context of the depression guideline.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will consider establishing a national clinical audit for people living with mesothelioma to understand a) the need for preventative measures and b) the scale of treatment needed.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to the answer I gave to the Hon. Member for Loughborough on 12 May 2025 to Question 46503.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will consider specific funding for mesothelioma nursing posts.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Decisions about recruitment are a matter for individual National Health Service employers, who manage this at a local level to ensure they have the staff they need to deliver safe and effective care.
Funding provided to NHS trusts is not ringfenced for specific items such as staffing levels. Hospitals receive funding allocations which they can use at their discretion, based on local priorities.
The 10 Year Workforce Plan will ensure that the NHS has the right people in the right places, with the right skills to care for patients, when they need it.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made on the potential merits of statutory regulation of therapy titles.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Titles can only be protected for statutorily regulated professions. Some regulated professions include the term ‘therapist’ and as such have protected title status, for example Art therapist, Dental therapist, and Occupational therapist. Therapists in general are not a statutorily regulated profession in the United Kingdom. The Government has not made an assessment on the merits of protecting all therapy titles.
The Government is clear that the professions protected in law must be the right ones and that the level of regulatory oversight must be proportionate to the risks to the public.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness among young people of the risks of sudden cardiac death in (a) grassroots sports clubs and (b) higher education settings.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
To reduce the risks of sudden cardiac death, NHS England has a published a national service specification for Inherited Cardiac Conditions that covers patients who often present as young adults with previously undiagnosed cardiac disease or as families requiring follow up due to a death from this cause. This describes the service model and guidance that should be followed to support the diagnosis and treatment of patients or family members. It also includes the requirement for specialised Inherited Cardiac Conditions services to investigate suspected cases.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to introduce screening for asymptomatic heart conditions in young people in sports settings.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to the answer I gave on 27 October 2025 to Question 78454.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness among young people of the risks of sudden cardiac death in (a) grass roots sports clubs and (b) higher education settings.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
To reduce the risks of sudden cardiac death, NHS England has published a national service specification for inherited cardiac conditions that covers patients who often present as young adults with previously undiagnosed cardiac disease or families requiring follow-up due to a death from this cause. This describes the service model and guidance that should be followed to support diagnosis and treatment of patients or family members. It also includes the requirement for specialised inherited cardiac conditions services to investigate suspected cases.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to gather additional data on the (a) effectiveness and (b) safety of the Respiratory Syncytial Virus vaccination in people that are over 80.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) monitors vaccine safety. The UKHSA and the MHRA are in regular contact with manufacturers over new and emerging data from their products.
Evidence of effectiveness and safety in relevant age groups in the United States of America, which implemented older adult vaccination a season ahead of the United Kingdom, was used to inform the Joint Committee on Vaccination and Immunisation’s (JCVIs) considerations on extending the UK programme to adults aged 80 years old and older. The JCVI’s meeting minutes and statement of 16 July 2025 advising an extension to the UK respiratory syncytial virus (RSV) programme are available at the following link:
https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation
The JCVI keeps the RSV programme under regular review. Evidence on the safety and effectiveness of RSV vaccines in all age groups in all countries where data has been made available is used to inform JCVI advice.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to introduce screening for asymptomatic heart conditions in young people in sports settings.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
In the United Kingdom, national screening programmes are introduced based on the recommendations of the UK National Screening Committee (UK NSC), an independent scientific advisory committee which advises ministers and the National Health Service in all four countries on all aspects of population and targeted screening and which supports implementation.
The UK NSC last reviewed screening for sudden cardiac death (SCD) in people under the age of 39 years old in 2019 and concluded that population screening should not be offered. Further information is available at the following link:
https://view-health-screening-recommendations.service.gov.uk/sudden-cardiac-death/
The UK NSC is currently examining the evidence for SCD screening and will open a public consultation to seek comments from members of the public and stakeholders on this in due course.